Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.
about
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmissionAn economic analysis of poliovirus risk management policy options for 2013-2052Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsCharacterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.The potential impact of expanding target age groups for polio immunization campaigns.Preeradication vaccine policy options for poliovirus infection and disease control.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.Systematic Review of Measles and Rubella Serology Studies.Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.Poliovirus vaccination during the endgame: insights from integrated modeling.Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes.Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I.Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination.The risk of type 2 oral polio vaccine use in post-cessation outbreak response.Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.Modeling the dynamics of oral poliovirus vaccine cessation.Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.Modelling Risk to US Military Populations from Stopping Blanket Mandatory Polio Vaccination.Modeling population immunity to support efforts to end the transmission of live polioviruses.Models and analyses to understand threats to polio eradication.Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.Modeling poliovirus risks and the legacy of polio eradication.Quantitative Microbial Risk Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric Pathogens.Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
P2860
Q33873406-6D97819A-B06C-4B29-9F9B-4FB1C5D3F9DCQ35131980-916D336F-0F0D-405C-B81E-34BB8B7FDD74Q35662053-20A9F58D-7616-4944-8120-761161F710FBQ35779660-3FC491E0-BCD7-42A1-BFAC-95DA2BD8ADD7Q35779733-6658953D-EE50-4207-9AFB-5C8CC11A9C2CQ35779856-750AC47C-02C1-442B-8C3F-E5B2DCCA45F5Q35787304-8DBC91F9-F744-46B4-9DAB-719AE1803E93Q35787331-112A886E-B8B0-40ED-8802-28A774DBDC4AQ35968325-8F4AF3B2-F1B0-483E-AA68-470E37BD8EBEQ36031421-C1867944-0635-48F1-A9A5-0197E657E9ACQ36035498-BE1E9477-8268-4026-9B24-1CD834563FF5Q37542082-4F49E695-04DB-45A7-8010-B1A3D37C6CA0Q37568832-A591305D-E4CD-4E06-A04C-194BBC80A116Q38086593-CDC6574D-0D7D-4D62-A335-D9DC7756DF6BQ38087428-1441946D-FB2A-4A74-9171-9B55631C96FCQ38168905-8152B21F-AC93-4CFE-9209-34F7FB8C447FQ38323836-B218D8A9-5829-4728-8F0B-EB5BFA9DEBE8Q38528489-92F7C7FA-29D0-44C4-9ED1-F64DA8F50AC2Q38754363-396193E0-748C-4B8D-9E0B-9737DD0E006AQ38796753-926A1DE1-F467-438B-9C13-59AD30C5E92BQ38914168-0F2581A7-1896-4DCC-A955-B27BB0C91568Q38976888-CE5714E0-D3A1-4DAC-A6DF-FACD5A5BD2F2Q39112948-EEE4DF69-0CED-4F4F-ACBA-68F3938B5450Q39258694-1DFECF24-7307-4DC6-A256-DF6F213EA887Q40071746-3C535C6E-34BC-4DDD-8164-5FC258ED8649Q40071754-5798E5D4-BB80-419B-8C7A-47CF96908123Q40611006-6F685183-0571-481D-B630-65AE3AF35663Q41692843-B99EDA3E-A7FA-4A7E-BC7D-A0F779A0E5E1Q41700694-E815B042-4A1C-413F-8421-33BDB67DD938Q41925239-D6F94CD6-C080-4368-A74C-997B1CC1BAF7Q42183578-C94267F0-05F0-4FBE-805E-19A80BB873CDQ42183580-2A5833D7-4BC6-4B56-9EB7-B14BBDDFB16BQ42183582-70E93A29-289A-490B-AFA6-0C1DE02D2079Q43373067-BA26DE12-AEC7-4F29-86CA-8922934128C4Q45326635-8DE38F7B-4488-4BD5-9C6B-C678D274CF70Q47119356-C8858D11-C142-472E-948C-F788B07FBAB3Q47556747-D0A5AE48-3828-4786-8B57-A3D244698C98Q53335042-20935194-32C6-456F-8AC4-B5992C95244EQ54231228-3AB95B3F-7BDF-482D-BAA0-85E2218CD5AEQ55114845-3B77F5FD-F9CB-4D12-9DE5-49EE1E754ACA
P2860
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@ast
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@en
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@nl
type
label
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@ast
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@en
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@nl
prefLabel
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@ast
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@en
Characterizing poliovirus tran ...... vaccine-related polioviruses.
@nl
P2093
P2860
P50
P356
P1433
P1476
Characterizing poliovirus tran ...... d vaccine-related polioviruses
@en
P2093
Dominika A Kalkowska
Stephen L Cochi
Steven G F Wassilak
P2860
P304
P356
10.1111/RISA.12044
P577
2013-03-22T00:00:00Z